BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Yu T, Liao X, Yang C, Han C, Zhu G, Huang K, Yu L, Qin W, Su H, Liu X, Peng T. The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma. Cancer Med 2018;7:966-80. [PMID: 29479826 DOI: 10.1002/cam4.1299] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Fang T, Wang Y, Yin X, Zhang L, Zhang X, Zhang D, Zhang Y, Wang X, Wang H, Xue Y. Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer. BMC Cancer 2022;22:635. [PMID: 35681154 DOI: 10.1186/s12885-022-09594-1] [Reference Citation Analysis]
2 Xu Z, Wu Z, Zhang J, Zhou R, Wu J, Yu B. Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis. Biomed Res Int 2020;2020:5603958. [PMID: 32851080 DOI: 10.1155/2020/5603958] [Reference Citation Analysis]
3 Gong YZ, Ruan GT, Liao XW, Wang XK, Liao C, Wang S, Gao F. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma. Oncol Rep 2019;42:923-36. [PMID: 31322253 DOI: 10.3892/or.2019.7216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
4 Li C, Zhou D, Jiang X, Liu M, Tang H, Mei Z. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Gene 2019;698:9-18. [PMID: 30825595 DOI: 10.1016/j.gene.2019.02.062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
5 Luo D, Zhang X, Li XK, Chen G. Identification of Key Functional Modules and Immunomodulatory Regulators of Hepatocellular Carcinoma. J Immunol Res 2021;2021:1801873. [PMID: 34423049 DOI: 10.1155/2021/1801873] [Reference Citation Analysis]
6 Zhou X, Li TM, Luo JZ, Lan CL, Wei ZL, Fu TH, Liao XW, Zhu GZ, Ye XP, Peng T. CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis. J Hepatocell Carcinoma 2021;8:1323-38. [PMID: 34765572 DOI: 10.2147/JHC.S335425] [Reference Citation Analysis]
7 Kodani SD, Morisseau C. Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation. Biochimie 2019;159:59-65. [PMID: 30716359 DOI: 10.1016/j.biochi.2019.01.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
8 Mu D, Qin F, Li B, Zhou Q. Identification of the Sixth Complement Component as Potential Key Genes in Hepatocellular Carcinoma via Bioinformatics Analysis. Biomed Res Int 2020;2020:7042124. [PMID: 33083480 DOI: 10.1155/2020/7042124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Li D, Yu T, Hu J, Wu J, Feng S, Xu Q, Zhu H, Zhang X, Zhang Y, Zhou B, Gu L, Zeng Z. Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome. Oxid Med Cell Longev 2021;2021:5175581. [PMID: 35003516 DOI: 10.1155/2021/5175581] [Reference Citation Analysis]
10 Wang Q, Tang Q, Zhao L, Zhang Q, Wu Y, Hu H, Liu L, Liu X, Zhu Y, Guo A, Yang X. Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development. Cancer Biol Med 2020;17:401-17. [PMID: 32587777 DOI: 10.20892/j.issn.2095-3941.2019.0335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ashida R, Okamura Y, Ohshima K, Kakuda Y, Uesaka K, Sugiura T, Ito T, Yamamoto Y, Sugino T, Urakami K, Kusuhara M, Yamaguchi K. The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma. Oncotarget 2018;9:22058-68. [PMID: 29774122 DOI: 10.18632/oncotarget.25178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Hu DG, Mackenzie PI, Nair PC, McKinnon RA, Meech R. The Expression Profiles of ADME Genes in Human Cancers and Their Associations with Clinical Outcomes. Cancers (Basel) 2020;12:E3369. [PMID: 33202946 DOI: 10.3390/cancers12113369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Wang X, Liao X, Yang C, Huang K, Yu T, Yu L, Han C, Zhu G, Zeng X, Liu Z, Zhou X, Qin W, Su H, Ye X, Peng T. Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy. Oncol Rep 2019;41:1586-602. [PMID: 30628708 DOI: 10.3892/or.2019.6953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Cao T, Yi SJ, Wang LX, Zhao JX, Xiao J, Xie N, Zeng Z, Han Q, Tang HO, Li YK, Zou J, Wu Q. Identification of the DNA Replication Regulator MCM Complex Expression and Prognostic Significance in Hepatic Carcinoma. Biomed Res Int 2020;2020:3574261. [PMID: 32964028 DOI: 10.1155/2020/3574261] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]